The ECBS 2021 brings together scientists from Europe and overseas to present and discuss their latest achievements in cutting edge chemical sciences at the interface with biology and medicine, ranging from new therapeutic approaches to resistant pathogens and viral infections (special session on COVID19 research), to targeting of proteasome and protein aggregation, natural products, artificial intelligence in drug discovery, nanostructured biomaterials, synthetic biology, glycochemistry and biology, chemistry of life origin.

I was selected to present my work in a special section on Artificial intelligence & computational drug design and my talk was entitled  "From probe to drug: polypharmacology across drug discovery". Website